| Net Cash Provided by (Used in) Operating Activities |
$50,498,000 |
USD |
-34% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$76,332,000 |
USD |
-41% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
51,975,626 |
shares |
-2.6% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$25,834,000 |
USD |
-213% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,931,000 |
USD |
-87% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$87,214,000 |
USD |
-3.8% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,009,701,000 |
USD |
-1.4% |
Q3 2025 |
Q3 2025 |